Loading...

Veeral Ajmera

TitleAssistant Professor Of Clinical
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #0887
La Jolla CA 92093
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, Hooker J, Sy E, Behling C, Xu R, Middleton MS, Valasek MA, Faulkner C, Rizo E, Richards L, Sirlin CB, Loomba R. Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 Apr 13. PMID: 29660324.
      View in: PubMed
    2. Caussy C, Hsu C, Lo MT, Liu A, Bettencourt R, Ajmera V, Bassirian S, Hooker J, Sy E, Richards L, Schork N, Schnabl B, Brenner DA, Sirlin CB, Chen CH, Loomba R. Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology. 2018 Mar 23. PMID: 29572891.
      View in: PubMed
    3. Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. Clin Gastroenterol Hepatol. 2018 Mar 14. PMID: 29378307.
      View in: PubMed
    4. Azeem N, Ajmera V, Hameed B, Mehta N. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatol Commun. 2018 Apr; 2(4):349-353. PMID: 29619414.
      View in: PubMed
    5. Ajmera V, Loomba R. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis? Semin Liver Dis. 2018 Feb; 38(1):14-20. PMID: 29471562.
      View in: PubMed
    6. Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, Sy E, Rizo E, Richards L, Sirlin CB, Loomba R. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018 Apr; 67(4):1348-1359. PMID: 29108123.
      View in: PubMed
    7. Ajmera V, Loomba R. Do Zones of Hepatic Steatosis Associate With Subtypes and Progression of Nonalcoholic Fatty Liver Disease in Children? Clin Gastroenterol Hepatol. 2018 Mar; 16(3):341-342. PMID: 29199148.
      View in: PubMed
    8. VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017 11; 153(5):1260-1272.e3. PMID: 28802566.
      View in: PubMed
    9. Perito ER, Ajmera V, Bass NM, Rosenthal P, Lavine JE, Schwimmer JB, Yates KP, Diehl AM, Molleston JP, Murray KF, Scheimann A, Gill R, Glidden D, Aouizerat B. Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2017 Sep; 1(7):609-622. PMID: 29130075.
      View in: PubMed
    10. Ajmera V, Loomba R. Editorial: non-alcoholic fatty liver disease-a pandemic in need of novel treatments and endpoints. Aliment Pharmacol Ther. 2017 07; 46(1):65-66. PMID: 28589576.
      View in: PubMed
    11. Ajmera V, Terrault NA, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017 06; 65(6):2090-2099. PMID: 28100008.
      View in: PubMed
    12. Sarkar M, Wellons M, Cedars MI, VanWagner L, Gunderson EP, Ajmera V, Torchen L, Siscovick D, Carr JJ, Terry JG, Rinella M, Lewis CE, Terrault N. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. Am J Gastroenterol. 2017 May; 112(5):755-762. PMID: 28291240.
      View in: PubMed
    13. Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat BE. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017 01; 65(1):65-77. PMID: 27532276.
      View in: PubMed
    14. Ajmera V, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 May; 111(5):658-64. PMID: 27002796; PMCID: PMC4860097.
    15. Ajmera V. Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant. Hepatology. 2016 07; 64(1):309-10. PMID: 26517408; PMCID: PMC4851904.
    16. Dao DY, Seremba E, Ajmera V, Sanders C, Hynan LS, Lee WM. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure. Dig Dis Sci. 2012 May; 57(5):1349-57. PMID: 22198704; PMCID: PMC3565239.
    17. Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, Opio CK, Taylor R, Restrepo R, Munoz S, Fontana RJ, Lee WM. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2011 Jul; 18(7):e167-74. PMID: 21143345; PMCID: PMC4931904.